echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Many provinces spot check drugs, 280 batches of Chinese herbal pieces were found unqualified!

    Many provinces spot check drugs, 280 batches of Chinese herbal pieces were found unqualified!

    • Last Update: 2019-11-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] recently, the new drug quality announcements issued by Hubei and Jiangxi drug administration are related to Chinese herbal pieces Among them, 38 batches of drugs were found to be unqualified in Hubei Province, including 32 batches of Chinese herbal pieces; 269 batches of drugs were found to be unqualified in Jiangxi Province, including 167 batches of Chinese herbal pieces In fact, since November, many local drug administrations have issued the notice of unqualified examination of Chinese herbal pieces According to incomplete statistics, a total of 280 batches of Chinese herbal pieces were found unqualified Heilongjiang: 11 batches of Chinese herbal pieces are unqualified On November 22, 2019, Heilongjiang Drug Administration issued a notice saying that 11 batches of Chinese herbal pieces are unqualified after inspection Among them, 6 batches of substandard drugs are not produced by the labeling enterprise after being checked and confirmed by the provincial drug regulatory department of the place where the labeling enterprise is located From the list of 11 batches of unqualified Chinese herbal pieces, 11 batches of drugs from 10 manufacturers are involved The unqualified items in this sampling inspection include: properties, impurities, total ash, etc For the unqualified Chinese herbal pieces, the local drug supervision and administration department where the source unit is located has taken control measures such as sealing and detaining, and asked the sampled unit to stop selling and using the corresponding batch of products In addition, Heilongjiang Provincial Drug Administration has notified the relevant provincial (municipal) regulatory authorities to deal with the substandard pieces of traditional Chinese medicine produced by enterprises outside the province, and instructed the provincial drug regulatory authorities at all levels to investigate the illegal acts of producing, selling and using substandard pieces of traditional Chinese medicine in accordance with relevant laws and regulations, and investigate and deal with them according to law Hainan: six batches of Chinese herbal pieces were found to be unqualified On November 22, 2019, the drug administration of Hainan Province issued the notice on the spot check and inspection information of drugs in the 11th (total 50th) period in 2019 According to the notice, in October 2019, Hainan Province completed 285 batches of drug sampling, including 278 batches of provincial planned sampling, 7 batches of supervised sampling, 277 batches of qualified drugs and 8 batches of unqualified drugs Another 6 batches of Chinese herbal pieces were found to be unqualified, and the unqualified items related to properties and sulfur dioxide residue The drug administration of Hainan Province has organized the relevant municipal and county market supervision and administration bureaus to take necessary control measures such as sealing up, detaining, suspending sales, recalling and so on for the drugs whose test results do not conform to the regulations, and to investigate and deal with the production enterprises and the sampled units in accordance with the relevant laws and regulations Shandong: 64 batches of drugs do not meet the standards According to the notice on drug quality sampling (issue 5, 2019) issued by Shandong Drug Administration recently, 33 varieties and 64 batches of drugs from 45 manufacturers (compounding units) do not meet the standards after sampling The unqualified items in this sampling inspection include: ammonium salt, iron salt, thin layer chromatography, aflatoxin, chrysophanol, total ash, etc For non-conforming products and corresponding enterprises and units, Shandong drug administration requires relevant municipal market supervision administration to strengthen supervision, urge them to find out the cause of the problem, formulate and implement rectification measures, and effectively eliminate the potential risks The relevant municipal market supervision and Administration Bureau has taken control measures such as sealing up, detaining, suspending sales and product recall for the non-conforming products, and has seriously investigated and punished the relevant production enterprises (compounding units) and the sampled units according to relevant laws and regulations  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.